Day 22 of induction therapy is important for minimal residual disease assessment by flow cytometry in childhood acute lymphoblastic leukemia.
Day 22 of induction therapy is important for minimal residual disease assessment by flow cytometry in childhood acute lymphoblastic leukemia.
复制标题
DOI：
10.1016/j.leukres.2012.03.014
复制
发表时间：
2012-08
影响因子：
2.7
通讯作者：
Xiao‐jun Xu;Yongmin Tang;Hongqiang Shen;Hua Song;Shi-long Yang;Shu-wen Shi;Wei-qun Xu
中科院分区：
文献类型：
--
作者：
Xiao‐jun Xu;Yongmin Tang;Hongqiang Shen;Hua Song;Shi-long Yang;Shu-wen Shi;Wei-qun Xu
